AI drug hunters could give big pharma a run for its money


  • TECH Premium
  • Wednesday, 17 Jul 2019

A hand holding a bunch of pills in an open palm. Have are bottles of medicine as a background.

Machine-learning technology has beaten humans at games of chess and Go to worldwide fanfare. A demonstration of its eerily lifelike prowess in making phone calls to unsuspecting people went viral. 

But a less-noticed win for DeepMind, the artificial-intelligence arm of Google’s parent Alphabet Inc, at a biennial biology conference could upend how drugmakers find and develop new medicines. It could also dial up pressure on the world’s largest pharmaceutical companies to prepare for a technological arms race. Already, a new breed of upstarts are jumping into the fray. 

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Tech News

Elon Musk’s Twitter deal is proceeding, not ‘on hold’, executives tell staff Premium
New Twitter policy aims to pierce fog of war misinformation Premium
Twitter suspended his account. Then he launched a competing network Premium
Opinion: The end of Roe means we’ll be criminalised for more of our data Premium
U.S. launches $3.5 billion program to speed development of up carbon removal tech Premium
10-year-old girl died doing a TikTok choking 'challenge'. Her mother is suing the video platform Premium
Canada to announce ban on use Huawei and ZTE 5G equipment -source Premium
Schroders to oppose Amazon, Meta, Alphabet over worker, digital rights Premium
Musk's $44-billion deal for Twitter proceeding as expected - Bloomberg News Premium
WhatsApp to launch cloud-based tools, premium features for businesses Premium

Others Also Read